Valuation: Neuland Laboratories Limited

Market Cap 275B 2.86B 2.52B 2.38B 2.16B 4.06B 4.08B 28.53B 11.02B 140B 10.76B 10.52B 451B P/E 2027 *
57.5x
P/E 2028 * 44.1x
Enterprise Value 278B 2.89B 2.54B 2.4B 2.18B 4.1B 4.12B 28.79B 11.12B 142B 10.86B 10.62B 455B EV / Sales 2027 *
11.4x
EV / Sales 2028 * 9.43x
Free-Float
62.26%
Yield 2027 *
0.11%
Yield 2028 * 0.14%
1 day-0.33%
1 week-5.18%
Current month-6.85%
1 month-6.85%
3 months+18.27%
6 months+77.83%
Current year+40.63%
1 week 21,168.4
Extreme 21168.4
22,903.9
1 month 21,168.4
Extreme 21168.4
24,235.05
Current year 11,500
Extreme 11500
24,235.05
1 year 11,500
Extreme 11500
24,235.05
3 years 3,612.05
Extreme 3612.05
24,235.05
5 years 965.85
Extreme 965.85
24,235.05
10 years 247.3
Extreme 247.3
24,235.05
Manager TitleAgeSince
Chief Executive Officer 47 31/03/2026
Director of Finance/CFO - 22/11/2022
Chief Tech/Sci/R&D Officer - 28/02/2023
Director TitleAgeSince
Director/Board Member 50 31/12/2001
Chairman 82 06/01/1984
Director/Board Member 47 28/02/2007
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%-5.18%+48.13%+478.85% 2.86B
+0.11%+1.71%+63.52%+117.61% 1,056B
+0.27%+0.92%+51.33%+73.35% 655B
+0.73%+0.68%+20.70%+74.90% 471B
-1.36%-2.58%+40.20%+42.33% 342B
+1.34%+4.53%+23.37%+29.55% 277B
-0.48%-0.54%+13.56%+13.50% 257B
+0.85%+6.35%+53.17%+54.39% 226B
+0.85%+1.10%+35.78%+101.82% 189B
-0.30%-2.98%-27.62%-61.28% 170B
Average +0.08%+0.36%+32.21%+92.50% 364.58B
Weighted average by Cap. -0.05%+1.04%+40.71%+70.26%

Financials

2027 *2028 *
Net sales 24.43B 255M 224M 212M 192M 361M 363M 2.53B 979M 12.47B 956M 935M 40.07B 29.27B 305M 268M 254M 230M 432M 434M 3.04B 1.17B 14.93B 1.14B 1.12B 47.99B
Net income 4.8B 49.99M 43.96M 41.57M 37.71M 70.82M 71.23M 498M 192M 2.45B 188M 184M 7.87B 6.26B 65.26M 57.4M 54.28M 49.23M 92.46M 92.99M 650M 251M 3.2B 245M 240M 10.27B
Net Debt 2.56B 26.68M 23.47M 22.19M 20.13M 37.8M 38.02M 266M 103M 1.31B 100M 98M 4.2B 979M 10.2M 8.97M 8.49M 7.7M 14.45M 14.54M 102M 39.24M 500M 38.3M 37.48M 1.61B
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
2,183
Date Price Change Volume
29/09/26 ₹21,381.70 -0.24% 1,419
28/09/26 ₹21,433.15 -2.15% 1,917
25/09/26 ₹21,903.95 -0.02% 4,310
24/09/26 ₹21,909.40 -2.60% 2,043
23/09/26 ₹22,493.30 -0.16% 1,008
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
21,433.15INR
Average target price
24,334.75INR
Spread / Average Target
+13.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEULANDLAB Stock